APA (7th ed.) Citation

Bednarski, M., Otto, M., Dudek, M., Siwek, A., Zygmunt, M., Knutelska, J., . . . Sapa, J. (2016). Antiarrhythmic activity in occlusion-reperfusion model of 1-(1H-indol-4-yloxy)-3-{[2-(2-methoxyphenoxy)ethyl]amino} propan-2-ol and its enantiomers. Clinical & Experimental Pharmacology & Physiology, 43(1), 81. https://doi.org/10.1111/1440-1681.12491

Chicago Style (17th ed.) Citation

Bednarski, Marek, Monika Otto, Magdalena Dudek, Agata Siwek, Małgorzata Zygmunt, Joanna Knutelska, Leszek Nowiński, Grażyna Groszek, and Jacek Sapa. "Antiarrhythmic Activity in Occlusion-reperfusion Model of 1-(1H-indol-4-yloxy)-3-{[2-(2-methoxyphenoxy)ethyl]amino} Propan-2-ol and Its Enantiomers." Clinical & Experimental Pharmacology & Physiology 43, no. 1 (2016): 81. https://doi.org/10.1111/1440-1681.12491.

MLA (9th ed.) Citation

Bednarski, Marek, et al. "Antiarrhythmic Activity in Occlusion-reperfusion Model of 1-(1H-indol-4-yloxy)-3-{[2-(2-methoxyphenoxy)ethyl]amino} Propan-2-ol and Its Enantiomers." Clinical & Experimental Pharmacology & Physiology, vol. 43, no. 1, 2016, p. 81, https://doi.org/10.1111/1440-1681.12491.